In part 5 of this Exclusive Interview, Dr. Leigh Perreault talks with Diabetes in Control Medical Editor Joy Pape during the ADA meeting in San Diego, California, about her focus on healthy living and other possible treatment options in her discussions with frustrated prediabetes patients.
Read More »Leigh Perreault Part 6, GLP-1 And SGLT2 Medications for Pre-Diabetes Treatment
In part 6, the conclusion, of this Exclusive Interview, Dr. Leigh Perreault talks with Diabetes in Control Medical Editor Joy Pape during the ADA meeting in San Diego, California, about her recommendations regarding certain diabetes drugs as a treatment option for her prediabetes patients.
Read More »Three Patients, Three Solutions
I have had several patients who did well at first with their GLP-1 agonists. Patient 1: Man, 46 years of age, used liraglutide 3mg daily for obesity. Patients 2 & 3: 2 women in their 60s were using liraglutide for type 2 diabetes & weight.
Read More »Sood & Messer Part 3, Transitioning from Public Health to Private Practice
Drs. Sood and Messer talk with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the positives of their practice model and their difference from other physicians.
Read More »Albuminuria: A Lot More Than Just a Little Protein in the Urine Part 3
In this week's Homerun Slides, the summary of the role of plasma protein (S1P) in glycocalyx protection.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #89: Lipid and Lipoprotein Metabolism, Hypolipidemic Agents, and Therapeutic Goals Part 1
Any discussion of lipid and lipoprotein metabolism in diabetes mellitus, especially type 2 diabetes mellitus (T2DM), must consider the role of insulin resistance (IR). IR plays a central role in the abnormal lipid and lipoprotein metabolism of T2DM [1] as evidenced by the characteristic set of lipid and lipoprotein abnormalities accompanying IR, even in the absence of frank hyperglycemia or abnormal glucose tolerance. Individuals with IR have low plasma levels of HDL-C and elevations in plasma triglyceride (TG) levels compared with levels seen in individuals who have normal insulin sensitivity. There is also an increase in the proportion of low-density lipoprotein (LDL) particles that are small, dense, and cholesterol ester-poor. I
Read More »Medipin® — to Detect Neuropathy
The pinprick or sharp sensation test is acknowledged and recommended by the ADA as a useful and sensitive method of testing for Loss Of Protective Sensation and predicting serious complications associated with diabetes. Medipin is a unique single use cutaneous pinprick testing device. Its patented precision technology has been designed to enhance patient pinprick sensation response.
Read More »Is Sitting Really the New Smoking?
Make no mistake: sitting less time overall is a good idea for myriad health reasons, but is sitting as bad for you as some would suggest? Is it really the new smoking? In 2017 alone, a slew of new research studies has looked at various health detriments associated with prolonged sitting, even in adults who exercise regularly.
Read More »Telephone Counseling for Patients with Diabetes
Technological support deemed beneficial for glycemic control
Read More »Predicting Adverse Perinatal Outcomes in Gestational Diabetes
Is a single fasting glucose measurement sufficient to predict risk of adverse perinatal outcomes?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.